Logo do repositório
 
Publicação

Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents

2023-12-15Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorGouveia, Teresa I. A.
dc.contributor.authorGorito, Ana M.
dc.contributor.authorCristóvão, Maria B.
dc.contributor.authorPereira, Vanessa J.
dc.contributor.authorCrespo, João G.
dc.contributor.authorAlves, Arminda
dc.contributor.authorPereira, M. Fernando R.
dc.contributor.authorRibeiro, Ana R. L.
dc.contributor.authorSilva, Adrián M. T.
dc.contributor.authorSantos, Mónica S. F.
dc.contributor.institutionLAQV@REQUIMTE
dc.contributor.institutionDQ - Departamento de Química
dc.contributor.institutionInstituto de Tecnologia Química e Biológica António Xavier (ITQB)
dc.contributor.pblAcademic Press | Elsevier
dc.date.accessioned2024-03-05T00:13:01Z
dc.date.available2024-03-05T00:13:01Z
dc.date.issued2023-12-15
dc.descriptionFunding Information: This research was financially supported by: (i) Project POCI-01-0145-FEDER-031297 (CytoStraTech)—funded by FEDER funds through COMPETE2020—Programa Operacional Competitividade e Internacionalização (POCI) and by national funds (PIDDAC) through FCT /MCTES; (ii) NORTE-01-0145-FEDER-000069 (Healthy Waters) co-funded by European Regional Development Fund (ERDF), through North Portugal Regional Operational Programme (NORTE2020), under the PORTUGAL 2020 Partnership Agreement; (iii) 2022.08738.PTDC (DRopH2O) funded by national funds through FCT/MCTES (PIDDAC); (iv) UIDB/04750/2020 (EPIUnit) and LA/P/0064/2020 (ITR), funded by national funds through the FCT - Foundation for Science and Technology, I.P.; (v) LA/P/0045/2020 (ALiCE), Base Fundings UIDB/00511/2020 and UIDP/00511/2020 (LEPABE) and UIDB/50020/2020 and UIDP/50020/2020 (LSRE-LCM), funded by national funds through FCT/MCTES (PIDDAC); and (vi) iNOVA4Health (UIDB/04462/2020 and UIDP/04462/2020) and LS4FUTURE Associated Laboratory (LA/P/0087/2020) financially supported by national funds through the FCT/MCTES. Associate Laboratory for Green Chemistry- LAQV which is financed by national funds from FCT/MCTES (UIDB/50006/2020 and UIDP/50006/2020) is gratefully acknowledged. Teresa I.A. Gouveia would like to thank the Portuguese Foundation for Science and Technology (FCT) for her Ph.D. grant (SFRH/BD/147301/2019). ARLR acknowledges FCT funding under the Scientific Employment Stimulus - Individual Call (2022.00184.CEECIND). Publisher Copyright: © 2023
dc.description.abstractOver the past years, there has been an increasing concern about the occurrence of antineoplastic drugs in water bodies. The incomplete removal of these pharmaceuticals from wastewaters has been confirmed by several scientists, making it urgent to find a reliable technique or a combination of techniques capable to produce clean and safe water. In this work, the combination of nanofiltration and ozone (O3)-based processes (NF + O3, NF + O3/H2O2 and NF + O3/H2O2/UVA) was studied aiming to produce clean water from wastewater treatment plant (WWTP) secondary effluents to be safely discharged into water bodies, reused in daily practices such as aquaculture activities or for recharging aquifers used as abstraction sources for drinking water production. Nanofiltration was performed in a pilot-scale unit and O3-based processes in a continuous-flow column. The peroxone process (O3/H2O2) was considered the most promising technology to be coupled to nanofiltration, all the target pharmaceuticals being removed at an extent higher than 98% from WWTP secondary effluents, with a DOC reduction up to 92%. The applicability of the clean water stream for recharging aquifers used as abstraction sources for drinking water production was supported by a risk assessment approach, regarding the final concentrations of the target pharmaceuticals. Moreover, the toxicity of the nanofiltration retentate, a polluted stream generated from the nanofiltration system, was greatly decreased after the application of the peroxone process, which evidences the positive impact on the environment of implementing a NF + O3/H2O2 process.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent10
dc.format.extent3002997
dc.identifier.doi10.1016/j.jenvman.2023.119314
dc.identifier.issn0301-4797
dc.identifier.otherPURE: 83896836
dc.identifier.otherPURE UUID: 5d605dfb-ba06-41ab-8502-82038b7d3d85
dc.identifier.otherScopus: 85174031655
dc.identifier.otherPubMed: 37857217
dc.identifier.otherORCID: /0000-0001-8714-3781/work/154654709
dc.identifier.urihttp://hdl.handle.net/10362/164428
dc.identifier.urlhttps://www.scopus.com/pages/publications/85174031655
dc.language.isoeng
dc.peerreviewedyes
dc.subjectAnticancer drugs
dc.subjectCytostatics
dc.subjectNanofiltration
dc.subjectOzonation
dc.subjectPeroxone
dc.subjectRisk assessment
dc.subjectWastewater effluent
dc.subjectEnvironmental Engineering
dc.subjectWaste Management and Disposal
dc.subjectManagement, Monitoring, Policy and Law
dc.subjectSDG 3 - Good Health and Well-being
dc.subjectSDG 6 - Clean Water and Sanitation
dc.subjectSDG 11 - Sustainable Cities and Communities
dc.subjectSDG 14 - Life Below Water
dc.titleNanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluentsen
dc.typejournal article
degois.publication.titleJournal of Environmental Management
degois.publication.volume348
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
Nanofiltration_combined_with_ozone-based.pdf
Tamanho:
2.86 MB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

Home collection (FCT)